Interestingly, activating mutations in NRR and PEST domains of Notch3 have been described in several tumor cell lines, including an NRR mutation in a human TALL1 cell line that likely makes the S2 site more accessible to ADAM metalloproteases [6]. The gene discussed is NOTCH3; the disease is neoplasm.